A Pro‐Regenerative Supramolecular Prodrug Protects Against and Repairs Colon Damage in Experimental Colitis

Abstract Structural repair of the intestinal epithelium is strongly correlated with disease remission in inflammatory bowel disease (IBD); however, ulcer healing is not addressed by existing therapies. To address this need, this study reports the use of a small molecule prolyl hydroxylase (PHD) inhi...

Full description

Bibliographic Details
Main Authors: Kelsey G. DeFrates, Elaine Tong, Jing Cheng, Ellen Heber‐Katz, Phillip B. Messersmith
Format: Article
Language:English
Published: Wiley 2024-04-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202304716
_version_ 1797227539050004480
author Kelsey G. DeFrates
Elaine Tong
Jing Cheng
Ellen Heber‐Katz
Phillip B. Messersmith
author_facet Kelsey G. DeFrates
Elaine Tong
Jing Cheng
Ellen Heber‐Katz
Phillip B. Messersmith
author_sort Kelsey G. DeFrates
collection DOAJ
description Abstract Structural repair of the intestinal epithelium is strongly correlated with disease remission in inflammatory bowel disease (IBD); however, ulcer healing is not addressed by existing therapies. To address this need, this study reports the use of a small molecule prolyl hydroxylase (PHD) inhibitor (DPCA) to upregulate hypoxia‐inducible factor one‐alpha (HIF‐1α) and induce mammalian regeneration. Sustained delivery of DPCA is achieved through subcutaneous injections of a supramolecular hydrogel, formed through the self‐assembly of PEG‐DPCA conjugates. Pre‐treatment of mice with PEG‐DPCA is shown to protect mice from epithelial erosion and symptoms of dextran sodium sulfate (DSS)‐induced colitis. Surprisingly, a single subcutaneous dose of PEG‐DPCA, administered after disease onset, leads to accelerated weight gain and complete restoration of healthy tissue architecture in colitic mice. Rapid DPCA‐induced restoration of the intestinal barrier is likely orchestrated by increased expression of HIF‐1α and associated targets leading to an epithelial‐to‐mesenchymal transition. Further investigation of DPCA as a potential adjunctive or stand‐alone restorative treatment to combat active IBD is warranted.
first_indexed 2024-04-24T14:42:24Z
format Article
id doaj.art-0f671bc2f0e6463e9ae2f5f92b3f1e88
institution Directory Open Access Journal
issn 2198-3844
language English
last_indexed 2024-04-24T14:42:24Z
publishDate 2024-04-01
publisher Wiley
record_format Article
series Advanced Science
spelling doaj.art-0f671bc2f0e6463e9ae2f5f92b3f1e882024-04-02T20:51:56ZengWileyAdvanced Science2198-38442024-04-011113n/an/a10.1002/advs.202304716A Pro‐Regenerative Supramolecular Prodrug Protects Against and Repairs Colon Damage in Experimental ColitisKelsey G. DeFrates0Elaine Tong1Jing Cheng2Ellen Heber‐Katz3Phillip B. Messersmith4Department of Bioengineering University of California, Berkeley Berkeley CA 94720 USADepartment of Bioengineering University of California, Berkeley Berkeley CA 94720 USADepartment of Bioengineering University of California, Berkeley Berkeley CA 94720 USALankenau Institute for Medical Research Wynnewood PA 19096 USADepartment of Bioengineering University of California, Berkeley Berkeley CA 94720 USAAbstract Structural repair of the intestinal epithelium is strongly correlated with disease remission in inflammatory bowel disease (IBD); however, ulcer healing is not addressed by existing therapies. To address this need, this study reports the use of a small molecule prolyl hydroxylase (PHD) inhibitor (DPCA) to upregulate hypoxia‐inducible factor one‐alpha (HIF‐1α) and induce mammalian regeneration. Sustained delivery of DPCA is achieved through subcutaneous injections of a supramolecular hydrogel, formed through the self‐assembly of PEG‐DPCA conjugates. Pre‐treatment of mice with PEG‐DPCA is shown to protect mice from epithelial erosion and symptoms of dextran sodium sulfate (DSS)‐induced colitis. Surprisingly, a single subcutaneous dose of PEG‐DPCA, administered after disease onset, leads to accelerated weight gain and complete restoration of healthy tissue architecture in colitic mice. Rapid DPCA‐induced restoration of the intestinal barrier is likely orchestrated by increased expression of HIF‐1α and associated targets leading to an epithelial‐to‐mesenchymal transition. Further investigation of DPCA as a potential adjunctive or stand‐alone restorative treatment to combat active IBD is warranted.https://doi.org/10.1002/advs.202304716HIF‐1αinflammatory bowel diseaseprolyl hydroxylase inhibitorregeneration
spellingShingle Kelsey G. DeFrates
Elaine Tong
Jing Cheng
Ellen Heber‐Katz
Phillip B. Messersmith
A Pro‐Regenerative Supramolecular Prodrug Protects Against and Repairs Colon Damage in Experimental Colitis
Advanced Science
HIF‐1α
inflammatory bowel disease
prolyl hydroxylase inhibitor
regeneration
title A Pro‐Regenerative Supramolecular Prodrug Protects Against and Repairs Colon Damage in Experimental Colitis
title_full A Pro‐Regenerative Supramolecular Prodrug Protects Against and Repairs Colon Damage in Experimental Colitis
title_fullStr A Pro‐Regenerative Supramolecular Prodrug Protects Against and Repairs Colon Damage in Experimental Colitis
title_full_unstemmed A Pro‐Regenerative Supramolecular Prodrug Protects Against and Repairs Colon Damage in Experimental Colitis
title_short A Pro‐Regenerative Supramolecular Prodrug Protects Against and Repairs Colon Damage in Experimental Colitis
title_sort pro regenerative supramolecular prodrug protects against and repairs colon damage in experimental colitis
topic HIF‐1α
inflammatory bowel disease
prolyl hydroxylase inhibitor
regeneration
url https://doi.org/10.1002/advs.202304716
work_keys_str_mv AT kelseygdefrates aproregenerativesupramolecularprodrugprotectsagainstandrepairscolondamageinexperimentalcolitis
AT elainetong aproregenerativesupramolecularprodrugprotectsagainstandrepairscolondamageinexperimentalcolitis
AT jingcheng aproregenerativesupramolecularprodrugprotectsagainstandrepairscolondamageinexperimentalcolitis
AT ellenheberkatz aproregenerativesupramolecularprodrugprotectsagainstandrepairscolondamageinexperimentalcolitis
AT phillipbmessersmith aproregenerativesupramolecularprodrugprotectsagainstandrepairscolondamageinexperimentalcolitis
AT kelseygdefrates proregenerativesupramolecularprodrugprotectsagainstandrepairscolondamageinexperimentalcolitis
AT elainetong proregenerativesupramolecularprodrugprotectsagainstandrepairscolondamageinexperimentalcolitis
AT jingcheng proregenerativesupramolecularprodrugprotectsagainstandrepairscolondamageinexperimentalcolitis
AT ellenheberkatz proregenerativesupramolecularprodrugprotectsagainstandrepairscolondamageinexperimentalcolitis
AT phillipbmessersmith proregenerativesupramolecularprodrugprotectsagainstandrepairscolondamageinexperimentalcolitis